Marcos González
Researcher Next ID · RN-023681
Researcher · Medicine
New York, Mexico
- Works count
- 634
- Citation count
- 29,601
- H-index
- 80
- i10-index
- 295
Research interests
Publications
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
Leukemia · 2017 · 10.1038/leu.2017.29
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Blood · 2016 · https://doi.org/10.1182/blood-2015-07-659144
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Nature · 2015 · https://doi.org/10.1038/nature14666
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
Blood · 2014 · https://doi.org/10.1182/blood-2014-01-550020
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Nature Genetics · 2011 · https://doi.org/10.1038/ng.1032
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Nature · 2011 · https://doi.org/10.1038/nature10113
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
Blood · 2010 · https://doi.org/10.1182/blood-2010-04-277434
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
Blood · 2008 · https://doi.org/10.1182/blood-2008-05-159632
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
Blood · 2008 · https://doi.org/10.1182/blood-2008-07-168617
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
Blood · 2008 · https://doi.org/10.1182/blood-2007-07-100669
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
Blood · 2007 · https://doi.org/10.1182/blood-2007-02-069625
Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.
PubMed · 2005
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
Leukemia · 2003 · https://doi.org/10.1038/sj.leu.2403202
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
Leukemia · 2003 · https://doi.org/10.1038/sj.leu.2403135
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.
PubMed · 2000
Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.
PubMed · 1999 · https://doi.org/10.1182/blood.v93.12.4365
Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy, and Cytogenetic Characteristics
Blood · 1999 · https://doi.org/10.1182/blood.v93.3.1032
Current projects
No projects listed.